Plant Health Care PLC Positive Developments with Harpin (2566H)
November 14 2018 - 1:00AM
UK Regulatory
TIDMPHC
RNS Number : 2566H
Plant Health Care PLC
14 November 2018
14 November 2018
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Positive Developments with Harpin ab in sugarcane in Brazil
Plant Health Care(R) , a leading provider of novel
patent-protected biological products to global agriculture markets,
is pleased to provide the following update on the launch of H2Copla
(Harpin ab) in sugarcane in Brazil.
Highlights:
- H2Copla (Harpin ab) has been applied on some 20,000 hectares
(Ha) of sugarcane since 'soft launch' in February 2018
- Average yield increases in excess of 20% are driving strong
demand; early adopters plan to switch entirely to H2Copla for the
next season
- Grower response to the results has been very positive
- Sales by PHC to Coplacana are expected to reach $0.8m in 2018,
pointing to strong growth in 2019
As previously announced, Brazil sugarcane, with 10 million Ha
planted, is an important target for Plant Health Care. The Company
has been developing Harpin ab for use in this crop since 2016.
Coplacana, a very large co-operative and the leading distributor of
inputs for sugarcane, was appointed as distributor to launch Harpin
ab under the brand name H2Copla. Following a 'soft launch' in
February 2018, Coplacana has been carrying out extensive
demonstration trials of the product; H2Copla has been applied on
some 20,000 Ha to date by various growers.
Trials conducted on behalf of the Company in 2018 showed that
single applications of a low dose (100 g per Ha), significantly
increased the yield of sugarcane (10-29%). Moreover, it is possible
that the life of the crop may be extended from five to six years,
resulting in a material cost reduction for the grower, especially
when sugar prices are low. Grower response to the results has been
very positive.
Furthermore Usina Açucareira Furlan S/A ('Furlan'), a large
sugarcane producer located in the state of São Paulo, carried out
field trials in 2018, as part of the soft launch by Coplacana,
which delivered an average 23% yield increase from H2Copla
applicatons. Furlan now plans to use H2Copla on their entire area
next season.
Gilmar Rorigues de Morais, Agriculture Department Manager at
Furlan, said "We are excited about the yield increases from this
year's trials and plan to use H2Copla on all of our 20,000 Ha for
the 2019 growing season."
Chris Richards, Executive Chairman and Interim CEO of Plant
Health Care, noted: "Grower reaction to demonstration trials of
H2Copla has been very positive. Growers have already treated some
20,000 Ha of sugarcane with the product. The indication that just
one customer (Furlan) plans to use H2Copla on 20,000 Ha next year,
points to significant revenue growth in 2019. Demand for Harpin ab
in Brazil is expected to reach at least $0.8m in 2018."
For further information, please contact:
Plant Health Care plc
Chris Richards, Executive Chairman and Interim CEO Tel: +1 919 926 1600
Jeff Tweedy, COO
Arden Partners plc - Nomad and Broker
John Llewellyn-Lloyd / Dan Gee-Summons Tel: +44 (0) 20 7614
5900
IFC Advisory - Financial PR
Graham Herring / Miles Nolan / Zach Cohen Tel: +44 (0) 20 3934
6633
Company website: www.planthealthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDUOUWRWSAAAAA
(END) Dow Jones Newswires
November 14, 2018 02:00 ET (07:00 GMT)
Plant Health Care (LSE:PHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Plant Health Care (LSE:PHC)
Historical Stock Chart
From Apr 2023 to Apr 2024